Ganeden warning letter revisited
This article was originally published in The Tan Sheet
Executive Summary
FDA reposted a warning letter on its Web site for Ganeden Biotech. FDA removed the 1letter in March while it was in discussions with Ganeden (2"The Tan Sheet" March 5, 2007, In Brief). An FDA spokesperson says no changes were made to the letter. The letter states some of the firm's Digestive Advantage products are misbranded foods and unapproved news drugs. The products were labeled as medical foods, which FDA says is incorrect...
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: